IP Group and Penn Medicine have both returned to back a series A round for Carisma Therapeutics, the Pennsylvania spinout formerly known as Carma.

Micro-infusion system developer Mercator MedSystems has received $11m in a round led by Salubris, which has licensed its technology in China.

A total of 22 participants have each received $100,000 in funding as part of the UC Berkeley accelerator.

The Merck GHI-backed medical device developer had raised $120m in funding prior to its initial public offering.

Virtual medical assistant developer MedWhat has hit back at investors including Stanford University and its StartX Fund with allegations they broke the law on eight separate counts.

Onyx Therapeutics-backed autoimmune drug developer Kezar Life Sciences has closed its initial public offering at $86.3m.

Steven Chackowicz will be responsible for identifying and commercialising research in the medical device sector.

The transplant-based medicine developer, backed by Alphabet, Partners Healthcare and Access Industries, floated in the middle of its range.